应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01066 威高股份
交易中 08-19 10:43:27
3.455
-0.035
-1.00%
最高
3.500
最低
3.430
成交量
243.80万
今开
3.500
昨收
3.490
日振幅
2.01%
总市值
155.75亿
流通市值
154.09亿
总股本
45.08亿
成交额
842.50万
换手率
0.05%
流通股本
44.60亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
探索约旦更便捷:Wego携手约旦旅游局为中东及北非游客推出“Ahlan Jordan”服务
美股速递 · 08-17 12:31
探索约旦更便捷:Wego携手约旦旅游局为中东及北非游客推出“Ahlan Jordan”服务
威高股份(01066.HK)获贝莱德增持272.72万股
中金财经 · 08-05
威高股份(01066.HK)获贝莱德增持272.72万股
贝莱德增持威高股份(01066.HK)272.72万股 每股作价约3.38港元
智通财经 · 08-05
贝莱德增持威高股份(01066.HK)272.72万股 每股作价约3.38港元
威高股份:贝莱德增持,好仓比例升至5.06%
港股披露 · 08-05
威高股份:贝莱德增持,好仓比例升至5.06%
威高股份7月股份变动月报:股本保持稳定
公告速递 · 08-04
威高股份7月股份变动月报:股本保持稳定
威高股份(01066)将于8月25日审议2026年中期业绩及派息方案
公告速递 · 07-27
威高股份(01066)将于8月25日审议2026年中期业绩及派息方案
大摩:威高股份目标价降至4.5港元 续予“与大市同步”评级
新浪港股 · 07-26
大摩:威高股份目标价降至4.5港元 续予“与大市同步”评级
大摩:降威高股份(01066)目标价至4.5港元 评级“与大市同步”
智通财经网 · 07-24
大摩:降威高股份(01066)目标价至4.5港元 评级“与大市同步”
大行评级|大摩:下调威高股份目标价至4.5港元,下调收入及盈利预测
格隆汇 · 07-24
大行评级|大摩:下调威高股份目标价至4.5港元,下调收入及盈利预测
威高股份7月22日回购79.00万股,涉资约262.65万港元
公告速递 · 07-22
威高股份7月22日回购79.00万股,涉资约262.65万港元
威高股份(01066.HK)7月22日斥资262.65万港元回购79万股
智通财经 · 07-22
威高股份(01066.HK)7月22日斥资262.65万港元回购79万股
威高股份:7月21日回购22万股,涉资约74.98万港元
公告速递 · 07-21
威高股份:7月21日回购22万股,涉资约74.98万港元
威高股份7月20日回购4万股,耗资约13.76万港元
公告速递 · 07-20
威高股份7月20日回购4万股,耗资约13.76万港元
威高股份(01066)7月20日斥资13.76万港元回购4万股
智通财经 · 07-20
威高股份(01066)7月20日斥资13.76万港元回购4万股
【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会
金吾财讯 · 07-17
【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会
威高股份(01066)公告:控股股东再度增持,累计购入3,055.24万股H股
公告速递 · 07-14
威高股份(01066)公告:控股股东再度增持,累计购入3,055.24万股H股
威高股份(01066.HK)获控股股东威高集团合共增持3055.24万股H股
智通财经 · 07-14
威高股份(01066.HK)获控股股东威高集团合共增持3055.24万股H股
威高股份:7月14日回购12.48万股,耗资约39.76万港元
公告速递 · 07-14
威高股份:7月14日回购12.48万股,耗资约39.76万港元
威高股份7月13日回购40万股 耗资约129.12万港元
公告速递 · 07-13
威高股份7月13日回购40万股 耗资约129.12万港元
威高股份(01066)7月13日斥资约129.12万港元回购40万股
智通财经 · 07-13
威高股份(01066)7月13日斥资约129.12万港元回购40万股
加载更多
公司概况
公司名称:
威高股份
所属市场:
SEHK
上市日期:
--
主营业务:
山东威高集团医用高分子制品股份有限公司是一家主要从事研发、生产及销售医疗器械产品的中国公司。该公司通过六个分部运营业务。医疗器械产品分部生产及销售临床护理、医学检验、麻醉及手术相关产品以及其他耗材。骨科产品分部生产及销售骨科产品(包括组织修复产品线)。介入产品分部生产及销售肿瘤及血管介入器械。药品包装产品分部生产及销售预充式注射器及冲管注射器。血液管理产品分部生产及销售血液採集、辐射、贮存、分离及灭菌消毒产品。其他分部从事融资租赁及保理业务。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01066","market":"HK","secType":"STK","nameCN":"威高股份","latestPrice":3.455,"timestamp":1787107378868,"preClose":3.49,"halted":0,"volume":2438000,"delay":0,"changeRate":-0.01002865329512898,"floatShares":4460000000,"shares":4508000000,"eps":0.4069288683240529,"marketStatus":"交易中","change":-0.035,"latestTime":"08-19 10:43:27","open":3.5,"high":3.5,"low":3.43,"amount":8424976,"amplitude":0.020057,"askPrice":3.46,"askSize":115200,"bidPrice":3.45,"bidSize":269600,"shortable":3,"etf":0,"ttmEps":0.4069288683240529,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1787112000000},"marketStatusCode":2,"adr":0,"listingDate":1077811200000,"exchange":"SEHK","adjPreClose":3.49,"dividendRate":0.052565,"openAndCloseTimeList":[[1787103000000,1787112000000],[1787115600000,1787126400000]],"volumeRatio":0.620791,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01066","defaultTab":"news","newsList":[{"id":"1153443372","title":"探索约旦更便捷:Wego携手约旦旅游局为中东及北非游客推出“Ahlan Jordan”服务","url":"https://stock-news.laohu8.com/highlight/detail?id=1153443372","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153443372?lang=zh_cn&edition=full","pubTime":"2026-08-17 12:31","pubTimestamp":1786941071,"startTime":"0","endTime":"0","summary":"探索约旦正变得前所未有的轻松。Wego与约旦旅游局联合推出“Ahlan Jordan”项目,专为中东及北非(MENA)地区的旅行者量身打造。这一合作旨在简化游客的行程规划,让更多人能够轻松领略约旦的独特魅力——从佩特拉古城的壮丽到死海的神奇漂浮,再到红海珊瑚礁的迷人海底世界。通过整合数字化工具与本地化内容,旅行者将能更便捷地获取住宿、交通及景点信息,享受无缝衔接的旅行体验。此举不仅提升了约旦作为旅游目的地的吸引力,也标志着中东地区旅游科技与官方推广的深度融合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0173614495.USD","01066","BK1589","LU0287142896.SGD","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657525519","title":"威高股份(01066.HK)获贝莱德增持272.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657525519","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657525519?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:57","pubTimestamp":1785941823,"startTime":"0","endTime":"0","summary":"格隆汇8月5日丨根据联交所最新权益披露资料显示,2026年7月31日,威高股份(01066.HK)获BlackRock, Inc.在场内以每股均价3.3812港元增持272.72万股,涉资约922.12万港元。\r\n\r\n 增持后,BlackRock, Inc.最新持股数目为228,724,820股,持股比例由4.99%上升至5.06%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/05/20260805409336.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/05/20260805409336.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260805/32327121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2430703178.SGD","BK1589","LU0173614495.USD","LU0320765489.SGD","LU1074936037.SGD","LU0648001328.SGD","FDFF","LU0208291251.USD","LU0731783048.USD","LU0980610538.SGD","IE00B3PB1722.GBP","LU1201861249.SGD","IE00B42XCP33.USD","BK4504","LU1481011671.HKD","LU1481011911.USD","LU1291159041.SGD","01066","LU2505996681.GBP","LU1670628061.USD","LU1509826696.USD","LU0130102774.USD","IE00B3QW5Z07.USD","IE00BDGV0183.EUR","LU0640476718.USD","BK4135","LU2505996509.AUD","LU0772969993.USD","LU2592432038.USD","LU1366333091.USD","BK4535","LU2264538146.SGD","BLK","BK4567","LU0157215616.USD","LU1064131342.USD","LU1280957306.USD","LU0731783394.SGD","LU1989771016.USD","LU2430703095.HKD","LU0070302665.USD","BK4534","IE00BVYPNV92.GBP","LU0287142896.SGD","BK1222","IE00BGHQF631.EUR","BK4581","BK4588","BK4533","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657154694","title":"贝莱德增持威高股份(01066.HK)272.72万股 每股作价约3.38港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657154694","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657154694?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:10","pubTimestamp":1785928232,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01066","LU0173614495.USD","BK1589","LU0287142896.SGD","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155211002","title":"威高股份:贝莱德增持,好仓比例升至5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155211002","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155211002?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:12","pubTimestamp":1785921134,"startTime":"0","endTime":"0","summary":"贝莱德于2026年7月31日以每股均价3.3812港元买入威高股份股份272.72万股,涉资约922.12万港元。贝莱德此次增持前持有威高股份好仓2.26亿股,占比4.99%;增持后持股量为2.29亿股,好仓比例升至5.06%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177428183","title":"威高股份7月股份变动月报:股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1177428183","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177428183?lang=zh_cn&edition=full","pubTime":"2026-08-04 14:25","pubTimestamp":1785824742,"startTime":"0","endTime":"0","summary":"2026年8月4日,威高股份公布2026年7月的股份变动月报。截至2026年7月31日,公司法定/注册股本总额为人民币457,063,232.4元,与上月底保持一致。报告显示,威高股份的普通股包括在香港联交所上市的H股和非上市股份两类。其中,H股的法定/注册股份数为4,522,332,324股,每股面值人民币0.1元;非上市普通股则为48,300,000股,同样每股面值人民币0.1元,两者在报告期内均未发生法定/注册股本变化。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193045036","title":"威高股份(01066)将于8月25日审议2026年中期业绩及派息方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1193045036","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193045036?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:05","pubTimestamp":1785143132,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司(01066,以下简称“威高股份”)7月27日公布董事会会议通知。公告显示,公司董事会将于2026年8月25日(星期二)召开会议,主要议程包括:\n\n1. 审议及批准威高股份及其附属公司截至2026年6月30日止六个月的未经审计中期业绩;\n\n2. 审议及批准上述中期业绩的发布;\n\n3. 研究派发中期股息事宜(如有)。\n\n公告同时列出公司现任董事会成员名单,包括4名执行董事、2名非执行董事及4名独立非执行董事。\n\n截至公告披露日,威高股份董事长为龙经。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654658050","title":"大摩:威高股份目标价降至4.5港元 续予“与大市同步”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2654658050","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654658050?lang=zh_cn&edition=full","pubTime":"2026-07-26 09:00","pubTimestamp":1785027600,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 摩根士丹利发布研报称,将威高股份(01066) 026至28年的收入预测下调1至2%,以反映常规耗材业务持续面对带量采购(VBP)及竞争的逆风,以及近期政策对骨科业务的影响,预计整体收入仅录得低单数增长。大摩将威高股份2026至28年的每股盈测分别下调11.8%、12.6%及13.5%,目标价由5.2港元下调至4.5港元,续予“与大市同步”评级。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-07-26/doc-inikassp3902843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EWH","01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653088646","title":"大摩:降威高股份(01066)目标价至4.5港元 评级“与大市同步”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653088646","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653088646?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:30","pubTimestamp":1784881832,"startTime":"0","endTime":"0","summary":"将威高股份(01066) 026至28年的收入预测下调1至2%,以反映常规耗材业务持续面对带量采购(VBP)及竞争的逆风,以及近期政策对骨科业务的影响,预计整体收入仅录得低单数增长。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260724/20260724163218_37673.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260724/20260724163218_37673.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471899.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["EWH","01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653709631","title":"大行评级|大摩:下调威高股份目标价至4.5港元,下调收入及盈利预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2653709631","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653709631?lang=zh_cn&edition=full","pubTime":"2026-07-24 14:10","pubTimestamp":1784873454,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0287142896.SGD","BK1589","01066","LU0173614495.USD","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101983294","title":"威高股份7月22日回购79.00万股,涉资约262.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101983294","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101983294?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:57","pubTimestamp":1784710677,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司于2026年7月22日公告,当日通过香港联交所场内回购79.00万股H股普通股,占回购前公司已发行股本的0.0177%,每股回购价介乎3.27港元至3.39港元,总金额约262.65万港元。截至公告日,公司股份总数仍为4,522,332,324股。根据公司于2026年5月29日通过的购回授权,威高股份可回购股份总数为4.46亿股,截至目前已合计回购约516.84万股,占购回授权通过当日公司已发行股本的1.1576%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份7月22日回购79.00万股,涉资约262.65万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653753729","title":"威高股份(01066.HK)7月22日斥资262.65万港元回购79万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653753729","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653753729?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:55","pubTimestamp":1784710548,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0173614495.USD","01066","BK1222","BK1589","LU0287142896.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173568742","title":"威高股份:7月21日回购22万股,涉资约74.98万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173568742","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173568742?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:05","pubTimestamp":1784635538,"startTime":"0","endTime":"0","summary":"威高股份于2026年7月21日发布公告,披露在香港联交所场内回购220,000股H股普通股,占回购前公司已发行股本的约0.0049%。本次回购每股价格介乎港币3.39元至3.42元不等,总耗资约74.98万港元。经本次回购后,公司已发行股份总数保持不变,仍为4,522,332,324股。其中,已发行股份减少至4,460,627,924股,库藏股增加至61,704,400股。该公告称,回购授权决议于2026年5月29日获通过,公司可回购的额度为446,464,632股。公司确认本次股份回购已遵守香港联交所证券上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份:7月21日回购22万股,涉资约74.98万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155228260","title":"威高股份7月20日回购4万股,耗资约13.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155228260","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155228260?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:32","pubTimestamp":1784557946,"startTime":"0","endTime":"0","summary":"山东威高集团医用高分子制品股份有限公司于2026年7月20日发布公告,披露当日于香港联交所场内回购了4万股H股,占此前已发行股本约0.0009%,每股回购价格为港币3.44元,涉资合计约港币13.76万元。回购授权于2026年5月29日获通过,公司可根据授权回购最多446,464,632股,目前已在香港联交所及其他市场合计回购4,158,400股,占授权总数约0.9314%。公司确认已遵守香港联交所证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份7月20日回购4万股,耗资约13.76万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652114952","title":"威高股份(01066)7月20日斥资13.76万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652114952","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652114952?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:30","pubTimestamp":1784557817,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份(01066)发布公告,该公司于2026年7月20日斥资13.76万港元回购4万股股份,每股回购价格为3.44港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0287142896.SGD","BK1222","01066","LU0173614495.USD","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652785473","title":"【券商聚焦】中信建投:建议关注Q2医疗设备高增长公司配置机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2652785473","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652785473?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:56","pubTimestamp":1784249774,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指,板块26Q1业绩整体承压。医疗设备预计Q2招标偏弱,部分企业新品及海外驱动增长;医疗器械上游部分公司收入有望高增长;高值耗材受医疗合规要求提升影响,部分企业预计增长良好;IVD低基数下增速有望改善;家用器械部分企业有望延续高增长;医疗服务边际有所回暖。建议关注Q2高增长公司的配置机会,建议关注国产替代向中高端延伸,看好出海、新科技(AI、脑机接口)及并购整合等新技术落地。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00241","BK1600","09996","BK1222","00853","06826","02252","BK1502","BK1142","BK1571","BK1583","BK1610","601066","BK1587","HK0000165453.HKD","BK1100","LU0173614495.USD","BK1574","BK1585","BK1247","01302","BK1584","BK1189","159873","02190","BK1615","02235","BK1589","BK1591","BK0276","BK1617","BK1515","BK1593","LU0287142896.SGD","01066","BK1161","KCE","BK1501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118573771","title":"威高股份(01066)公告:控股股东再度增持,累计购入3,055.24万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1118573771","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118573771?lang=zh_cn&edition=full","pubTime":"2026-07-14 18:40","pubTimestamp":1784025639,"startTime":"0","endTime":"0","summary":"2026年7月14日,威高股份发布自愿性公告称,其控股股东威高集团自2026年6月8日至公告日期,通过公开市场以自有资金累计购入公司15,598,800股H股,占公司已发行H股股份总数约0.34%,占公司已发行股份总数约0.34%。本次增持后,威高集团合计持有公司2,130,308,076股H股,占公司已发行H股股份总数的47.11%,占公司已发行股本总数的46.61%。公司提示,股东及潜在投资者在买卖公司证券时应审慎行事。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651724911","title":"威高股份(01066.HK)获控股股东威高集团合共增持3055.24万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651724911","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651724911?lang=zh_cn&edition=full","pubTime":"2026-07-14 18:39","pubTimestamp":1784025595,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0287142896.SGD","BK1589","01066","BK1222","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178934733","title":"威高股份:7月14日回购12.48万股,耗资约39.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178934733","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178934733?lang=zh_cn&edition=full","pubTime":"2026-07-14 17:23","pubTimestamp":1784021039,"startTime":"0","endTime":"0","summary":"威高股份于2026年7月14日发布翌日披露报表,披露公司于香港联交所场内进行了股份回购。公告显示,威高股份于2026年7月14日回购普通股H股共12.48万股,占本次回购前公司已发行股本约0.0028%,回购价格介乎每股3.17港元至3.20港元,总金额为约39.76万港元。此前,威高股份于2026年5月29日获股东大会通过股份购回授权,可购回的股份数量上限为约4.46亿股。截至最新公告披露,威高股份依据该授权累计于市场合计购回约411.84万股,占授权上限约0.9224%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份:7月14日回购12.48万股,耗资约39.76万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136091679","title":"威高股份7月13日回购40万股 耗资约129.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136091679","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136091679?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:36","pubTimestamp":1783935389,"startTime":"0","endTime":"0","summary":"威高股份(股票代码:01066)于2026年7月13日公告称,在香港联交所场内回购40万股H股。\n本次回购股份占回购前公司已发行股本(不包括库藏股)约0.009%,每股价格介乎3.21港元至3.26港元,合计动用约129.12万港元。回购完成后,公司已发行股本(不包括库藏股)降至4,461,012,724股,库藏股数量升至61,319,600股。\n根据公告,购回授权于2026年5月29日通过,发行人可根据授权合计回购446,464,632股。截至本次回购,公司于交易所合计购回3,993,600股。公司确认已遵守香港联交所证券上市规则及相关法律法规。\n本公告由公司秘书黄妙玲签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"威高股份7月13日回购40万股 耗资约129.12万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651190557","title":"威高股份(01066)7月13日斥资约129.12万港元回购40万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651190557","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651190557?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:35","pubTimestamp":1783935328,"startTime":"0","endTime":"0","summary":"智通财经APP讯,威高股份(01066)发布公告,于2026年7月13日该公司斥资约129.12万港元回购40万股,回购价格为每股3.21至3.26港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1466646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0173614495.USD","LU0287142896.SGD","BK1222","BK1589","01066"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.weigaogroup.com","stockEarnings":[{"period":"1week","weight":0.0295},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0289},{"period":"6month","weight":-0.3033},{"period":"1year","weight":-0.4664},{"period":"ytd","weight":-0.2908}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":0.037},{"period":"3month","weight":-0.007},{"period":"6month","weight":-0.0462},{"period":"1year","weight":0.0117},{"period":"ytd","weight":-0.0062}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东威高集团医用高分子制品股份有限公司是一家主要从事研发、生产及销售医疗器械产品的中国公司。该公司通过六个分部运营业务。医疗器械产品分部生产及销售临床护理、医学检验、麻醉及手术相关产品以及其他耗材。骨科产品分部生产及销售骨科产品(包括组织修复产品线)。介入产品分部生产及销售肿瘤及血管介入器械。药品包装产品分部生产及销售预充式注射器及冲管注射器。血液管理产品分部生产及销售血液採集、辐射、贮存、分离及灭菌消毒产品。其他分部从事融资租赁及保理业务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.3125,"avgChangeRate":-0.047385},{"month":2,"riseRate":0.625,"avgChangeRate":0.012817},{"month":3,"riseRate":0.4375,"avgChangeRate":0.016482},{"month":4,"riseRate":0.625,"avgChangeRate":0.016333},{"month":5,"riseRate":0.3125,"avgChangeRate":0.015578},{"month":6,"riseRate":0.5625,"avgChangeRate":-0.001902},{"month":7,"riseRate":0.625,"avgChangeRate":0.010815},{"month":8,"riseRate":0.470588,"avgChangeRate":0.012955},{"month":9,"riseRate":0.4375,"avgChangeRate":0.009721},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.007773},{"month":11,"riseRate":0.625,"avgChangeRate":0.002344},{"month":12,"riseRate":0.4375,"avgChangeRate":-0.007359}],"exchange":"SEHK","name":"威高股份","nameEN":"WEIGAO GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威高股份(01066)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威高股份(01066)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威高股份,01066,威高股份股票,威高股份股票老虎,威高股份股票老虎国际,威高股份行情,威高股份股票行情,威高股份股价,威高股份股市,威高股份股票价格,威高股份股票交易,威高股份股票购买,威高股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威高股份(01066)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威高股份(01066)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}